US patent on the “cancer mouse” sets a biotechnological milestone – how long ago was it?
The background
On April 12, 1988, the U.S. Patent Office granted Harvard University a patent on genetically modified non-human mammals. It became known through the so-called cancer mouse: built-in genetic makeup made the animals particularly susceptible to tumors. They should help investigate the origins of cancer and research possible treatments. What was new was not the breeding of laboratory animals, but rather the patent protection for animals modified in this way. This brought the connection between biotechnology, economic interests and animal protection into the public eye. The basic question was also important for Germany: How far can patent protection extend to living beings? The American patent was not automatically valid in this country. However, its granting made it clear that modern genetic engineering also presented the law with new tasks.